Asaf Danziger
2020
In 2020, Asaf Danziger earned a total compensation of $9M as Chief Executive Officer at NovoCure, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $934,607 |
|---|---|
| Salary | $781,868 |
| Stock Awards | $6,946,850 |
| Other | $293,379 |
| Total | $8,956,704 |
Danziger received $6.9M in stock awards, accounting for 78% of the total pay in 2020.
Danziger also received $934.6K in non-equity incentive plan, $781.9K in salary and $293.4K in other compensation.
Rankings
In 2020, Asaf Danziger's compensation ranked 1,001st out of 13,090 executives tracked by ExecPay. In other words, Danziger earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,001 out of 13,090 | 92nd |
Division Manufacturing | 351 out of 5,624 | 94th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 40 out of 799 | 95th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 18 out of 495 | 96th |
Industry Surgical and Medical Instruments and Apparatus | 12 out of 313 | 96th |
Source: SEC filing on April 27, 2021.
Danziger's colleagues
We found five more compensation records of executives who worked with Asaf Danziger at NovoCure in 2020.